Evidence map›Paper›PMID 34445181›Full record

ArticleInternational journal of molecular sciences2021

Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer.

Tilman L R Vogelsang, Aurelia Vattai, Elisa Schmoeckel, Till Kaltofen, Anca Chelariu-Raicu, Mingjun Zheng, Sven Mahner, Doris Mayr, Udo Jeschke, Fabian Trillsch

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Ultrasensitive quantification of trace amines based onJournal of pharmaceutical analysis · 2023
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Tilman L R VogelsangDepartment of Obstetrics and Gynecology, University Hospital, LMU Munich, 80337 Munich, Germany.
Aurelia VattaiDepartment of Obstetrics and Gynecology, University Hospital, LMU Munich, 80337 Munich, Germany.
Elisa SchmoeckelFaculty of Medicine, Institute of Pathology, LMU Munich, 80337 Munich, Germany.
Till KaltofenDepartment of Obstetrics and Gynecology, University Hospital, LMU Munich, 80337 Munich, Germany.ORCID 0000-0003-1137-211X
Anca Chelariu-RaicuDepartment of Obstetrics and Gynecology, University Hospital, LMU Munich, 80337 Munich, Germany.
Mingjun ZhengDepartment of Obstetrics and Gynecology, University Hospital, LMU Munich, 80337 Munich, Germany.
Sven MahnerDepartment of Obstetrics and Gynecology, University Hospital, LMU Munich, 80337 Munich, Germany.
Doris MayrFaculty of Medicine, Institute of Pathology, LMU Munich, 80337 Munich, Germany.
Udo JeschkeDepartment of Obstetrics and Gynecology, University Hospital, LMU Munich, 80337 Munich, Germany.ORCID 0000-0003-2623-3235
Fabian TrillschDepartment of Obstetrics and Gynecology, University Hospital, LMU Munich, 80337 Munich, Germany.ORCID 0000-0002-1860-4350
LMU Klinikum · DEUniversity Hospital Augsburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trace amine-associated receptor 1 (TAAR1) is a G

Indexed as

AgedCarcinoma, Ovarian EpithelialFemaleHumansMiddle AgedOvarian NeoplasmsPrognosisReceptors, G-Protein-CoupledThyroninesTrace Amine-Associated Receptors3-iodothyronamineReceptors, G-Protein-CoupledThyroninesTrace Amine-Associated Receptors3-iodothyronamineimmunohistochemistryovarian canceroverall survivalprognostic factorTAAR1

Identifiers

PMID34445181
PMCPMC8395182
OpenAlexW3190033971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.